CINQAIR (reslizumab)
Cinqair is indicated for add-on maintenance treatment of patients with severe asthma aged 18 years and older, and with an eosinophilic phenotype. Usually administered once every four weeks for a duration between 20 and 50 minutes. The recommended dose is 3mg/kg.
Please refer to the full prescribing information.
Note: Please speak with your healthcare provider for more information if you think this therapy might be right for you.
How do I make a referral or transition my treatment to Infusion Associates?
1. Ask your healthcare provider to fax us a completed order form for your medication, clinical notes, demographics and your insurance card to (833) 957-2188.
2. Providers can find order forms on our medications page.
3. One of our intake specialists will contact your healthcare provider to confirm receipt of your referral.
4. We will then verify benefits, obtain any required prior authorizations, and contact you to schedule an appointment.